Log in to save to my catalogue

Overview of Antiviral Drug Therapy for COVID-19: Where Do We Stand?

Overview of Antiviral Drug Therapy for COVID-19: Where Do We Stand?

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_77810099dabf420bab7b5e4ab1856ede

Overview of Antiviral Drug Therapy for COVID-19: Where Do We Stand?

About this item

Full title

Overview of Antiviral Drug Therapy for COVID-19: Where Do We Stand?

Publisher

Switzerland: MDPI AG

Journal title

Biomedicines, 2022-11, Vol.10 (11), p.2815

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

The vaccine weapon has resulted in being essential in fighting the COVID-19 outbreak, but it is not fully preventing infection due to an alarming spreading of several identified variants of concern. In fact, the recent emergence of variants has pointed out how the SARS-CoV-2 pandemic still represents a global health threat. Moreover, oral antiviral...

Alternative Titles

Full title

Overview of Antiviral Drug Therapy for COVID-19: Where Do We Stand?

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_77810099dabf420bab7b5e4ab1856ede

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_77810099dabf420bab7b5e4ab1856ede

Other Identifiers

ISSN

2227-9059

E-ISSN

2227-9059

DOI

10.3390/biomedicines10112815

How to access this item